FindTrial
Sign In

Efficacy evaluation of mirabilite application at Yifeng in the treatment of Bell's palsy in acute stage

Efficacy evaluation of mirabilite application at Yifeng in the treatment of Bell's palsy in acute stage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005583
Enrollment
Unknown
Registered
2022-02-01
Start date
2022-02-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial paralysis

Interventions

Control Group:medicine
Treatment Group:mirabilite application

Sponsors

Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Consistent with the diagnostic criteria of idiopathic facial paralysis;The course of disease was within 1-7 days;First attack on affected side; Voluntary informed consent

Exclusion criteria

Exclusion criteria: Central facial paralysisSecondary peripheral facial paralysis, such as facial paralysis caused by trauma, tumor, intracranial infection, surgery, etc;Hunt syndrome;Patients with primary critical or psychiatric diseases such as brain, heart, lung, liver, kidney and hematopoietic system Use of drugs or therapeutics that may cause peripheral neuropathy;A history of needle sickness;pregnant women.

Design outcomes

Primary

MeasureTime frame
House-Brackmann grading system;—

Secondary

MeasureTime frame
FDI;VAS score of postauricular pain;Sunnybrook;—

Countries

China

Contacts

Public ContactLiJia
lijia6617@126.com13585976617

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026